People with blood cancers, their supporters, and medical professionals argue that the absence of additional funding for medications in the Budget will result in another four years of “restricted access and harm to patients.”
A significant public outcry ensued following last year’s Budget when the anticipated funding for additional cancer medications was omitted, compelling the administration to later pledge an extra $604 million for Pharmac over a span of four years.
Nonetheless, Leukaemia & Blood Cancer New Zealand, the Blood Cancer Alliance, and the Cancer Society stated that although the government was “revisiting” last year’s commitments, this funding had been earmarked previously, leaving nothing available for additional therapies.
Together, they have urged the government to address Pharmac’s backlog of medications that lack funding.
Tim Edmonds, the CEO of Leukaemia & Blood Cancer New Zealand, stated that merely 180 individuals suffering from blood cancers received assistance from the previous year’s funding increase, which amounts to fewer than 1% of all New Zealanders dealing with such conditions.
This budget presented an opportunity to fulfill commitments for enhancing accessibility to cancer treatments; however, once more, individuals with blood cancers have been overlooked.
Many patients who were anticipating positive updates today might find that they cannot afford to wait an additional year.
In March, over 50 hematologists co-signed a letter to the government expressing their worries regarding how Pharmac was allocating funds. They characterized this approach as a “major healthcare policy blunder.”
Warnings were issued about deteriorating trust, diminished morale, and preventable fatalities resulting from delayed funding for medically approved treatments.
One of the agreement’s signatories, consulting hematologist Rodger Tiedemann, stated that New Zealand ranked last among OECD countries when it came to accessing contemporary medications.
The neglect towards us is evident in the 2025 Budget. Since when has it been acceptable for the New Zealand government to disregard the requirements of Kiwis battling blood cancer?
Each year, roughly 2800 individuals in New Zealand receive a diagnosis of blood cancer, and at present, there is no method available for preventing these cancers or screening for them beforehand.
The Cancer Society CEO, Nicola Coom, stated that medications were their main form of treatment.
This expanding cohort has once more been overlooked. Depending on individual donations and GoFundMe initiatives does not provide a resolution.
New Zealand needs to step up and provide funding for blood cancer medications. This budget has failed this community.
The Ōtaki resident Rob Crozier, who is 77 years old, was found to have Chronic Lymphocytic Leukemia (CLL) when he was 54.
At 77 years old, he continues to shell out $13,000 annually for health coverage that foots the bill for medicines endorsed in New Zealand but not officially funded.
However, that’s not available for everybody, and I’m unsure if they currently provide this type of insurance.
He was present at Parliament during Budget Day as a representative from CLL New Zealand, after advocating for increased funding for treatments over many years.
I was communicating with the former Health Minister Dr Shane Reti, who mentioned he was awaiting the Cancer Control Agency report on
availability of medications for blood cancers
, which was released last year.
We were hoping for at least a small boost in funding, yet disappointment struck once more.
Crozier highlighted that the disparity in how blood cancer patients are treated versus those with solid tumors is especially unjust considering the limited alternative options available.
Leukaemia can’t be treated with surgery or radiation—options typically available for other types of cancer—but can only be addressed through medication.
There are tons of amazing new medications available, but you can only get your hands on them if you have deep pockets. Unfortunately, I don’t fall into that category.
Sign up for Ngā Pitopito Kōrero
,
A daily newsletter handpicked by our editorial team and sent directly to your mailbox each weekday.